Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: A systematic review of randomized, controlled trials

Osteoporosis International

Volumn 16, Issue 10, 2005, Pages 1281-1290

  Knopp, Jennifer A ^a   Diner, Barry M ^b,e   Blitz, Maurice ^a,e   Lyritis, George P ^c   Rowe, Brian H ^d  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ATHENS   (Greece)

^d UNIVERSITY OF ALBERTA   (Canada)

^e NONE   (Canada)

Author keywords

Calcitonin; Osteoporosis; Pain; Vertebral fractures

Indexed keywords

CALCITONIN; PARACETAMOL; PLACEBO;

AGED; ANOREXIA; CALCULATION; COCHRANE LIBRARY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DIZZINESS; DRUG EFFECT; DRUG RESEARCH; DRUG SAFETY; ENTEROPATHY; FEMALE; FLUSHING; FRAGILITY FRACTURE; GASTROINTESTINAL SYMPTOM; HAND; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDLINE; MOBILIZATION; PAPER; PATIENT CARE; PRIORITY JOURNAL; PUBLICATION; REST; REVIEW; SCORING SYSTEM; SIDE EFFECT; SITTING; SPINAL PAIN; STANDING; TIME; VERTEBRA FRACTURE; VISUAL ANALOG SCALE; WALKING;

ACUTE DISEASE; AGED; ANALGESICS; BACK PAIN; BONE DENSITY CONSERVATION AGENTS; CALCITONIN; FEMALE; FRACTURES, COMPRESSION; HUMANS; MALE; OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIALS; SPINAL FRACTURES;

EID: 25844438772     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-004-1798-8     Document Type: Review

References (48)

1. Goeree R, O'Brien B, Petitte DB et al (1996) An assessment of the burden of illness due to osteoporosis in Canada. J Soc Obstet Gynaecol Can 18 July [Suppl 1]:5-24
2. NIH Consensus Statement. (2000) Mar 27-29; 17(1):1-45
3. Melton LJ 3rd, Kan SH, Frye KM et al (1989) Epidemiology of vertebral fractures in women. Am J Epidemiol 129:1000-1001
4. Melton LJ 3rd, Chrischilles EA, Lane AW, Riggs BL (1992) How many women have osteoporosis? J Bone Miner Res 9:1005-1010
5. Lukert BP (1994) Vertebral compression fractures: how to manage pain, avoid disability. Geriatrics 49(2):22-26
6. Lyritis GP, Mayasis B, Tsakalakos N, Lambropoulos A, Gazi S, Karachalios TH et al (1989) The natural history of the osteoporotic vertebral fracture. Clin Rheumatol 8[Suppl 2]:66-69
7. Plosker GL, McTavish D (1996) Intranasal Salcatonin (Salmon Calcitonin) A review of its pharmacological properties and role in the management of postmenopausal osteoporosis. Drugs Aging 8(5):378-400
8. Drage MP, Schug SA (1996) Analgesia in the elderly. Practical treatment recommendations. Drugs Aging 9(5):311-318
9. Gennari C (1989) Salmon calcitonin (Miacalcic) nasal spray in prevention and treatment of osteoporosis. Clin Rheumatol 8[Suppl 2]:61-65
10. Maksymowych WP (1998) Managing acute osteoporotic vertebral fractures with calcitonin. Can Fam Physician 44:2160-2166
11. Siminoski K, Josse RG (1996) Calcitonin in the treatment of osteoporosis. Can Med Assoc J 155:962-965
12. Schulz KF (1998) Randomized controlled trials. Clin Obstet Gynecol 4:245-256
13. Jadad AR, Moore RA, Carroll E, Jenkinson C, Reynolds DJM, Gavagham DJ et al (1996) Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 17:1-12
14. Schulz KF, Chalmers I, Hayes RJ, Altman DG (1995) Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273:408-412
15. Hedges LV, Olkin I (1985) Statistical methods for meta-analysis. Academic Press, Orlando, FL, USA
16. Begg CB, Mazundar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101
17. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634
18. De Pascalis MA, Fletzer DA, Spirito A (1983) Clinico-statistical study in patients with an arthrosis-osteoporosis picture in its painful stage treated with synthetic salmon calcitonin. [Studio clinico statistico su pazienti affetti da quadri di artrosiosteoporosi in fase algica trattati con calcitonina sintetica di salmone.] Clin Ther 107(3):177-184
19. Kapuscinski P, Talalaj M, Borowicz J, Marcinowska-Suchowierska E, Brzozowski R (1996) An analgesic effect of synthetic human calcitonin in patients with primary osteoporosis. Mater Med Pol 28(3):83-86
20. Combe B, Cohen C, Aubin F (1997) Equivalence of nasal spray and subcutaneous formulations of salmon calcitonin. Calcif Tissue Int 61:10-15
21. Dursun N, Dursun E, Yalcin S (2001) Comparison of alendronate, calcitonin and calcium treatments in postmenopausal osteoporosis. Int J Clin Pract 55:505-509
22. Palmieri LR (1993) Effect of s-calcitonin on pain related to recent osteoporotic vertebral fractures: a single-blind controlled clinical study against ipriflavone. [Effetto della calcitonina di salmone sul dolore provocato da recenti fratture vertebrali osteoporotiche: studio contollato in singolo cieco verso ipriflavone.] Acta Toxicol Ther XIV(2):73-83
23. Abellan Perez M, Bayina Garcia FJ, Calabozo M, Carpintero Benitez P, Figueroa Pedrosa M, Fernandez Crisostomo C et al (1995) Multicentric comparative study of synthetic salmon calcitonin nasally administered in the treatment of established postmenopausal osteoporosis. [Estudio comparativo multicentrico de la calcitonina sintetica de salmon, administrada por via nasal enel tratamiento de la osteoporosis postmenopausica establecida.] Ann Med Intern 12:12-16
24. Hernandez Cassis C, Cure Cure C, Hernandez Cassis S, Latorre A, Cure J, Crespo S et al (1985) Use of calcitonin in the multifactorial treatment of osteoporosis. [Uso de la calcitonina en el tratamiento multifactorial de la osteoporosis.] Salud Uninorte 2(1):3-12
25. Ljunghall S, Gardsell P, Johnell O, Larsson K, Lindh E, Obrant K et al (1991) Synthetic human calcitonin in post-menopausal osteoporosis: A placebo-controlled, double-blind study. Calcif Tissue Int 49:17-19
26. Mannarini M, Fincato G, Galimberti S, Maderna M, Greco F (1994) Analgesic effect of salmon calcitonin suppositories in patients with bone pain. Curr Ther Res Clin Exp 55:1079-1083
27. Orimo H, Fujita T, Yoshikawa S, Inoue T, Morita R (1994) Clinical study of SMC 20-051 nasal spray in pain due to osteoporosis. Clin Eval 22:211-231
28. Peichl P, Rintelen B, Kumpan W Broll H (1999) Increase of axial and appendicular trabecular and cortical bone density in established osteoporosis with intermittent nasal salmon calcitonin therapy. Gynecol Endocrinol 13:7-14
29. Pontiroli AE, Pajetta E, Scaglia L, Rubinacci A, Resmini G, Arrigoni M et al (1994) Analgesic effect of intranasal and intramuscular salmon calcitonin in post-menopausal osteoporosis: A double-blind, double-placebo study. Aging Clin Exp Res 6:459-463
30. Ringe JD (1990) Treatment of primary osteoporosis with calcium and salmon calcitonin. Dtsch Med Wochenschr 115:1176-1182
31. Blau LA, Hoehns JD (2003) Analgesic efficacy of calcitonin for vertebral fracture pain. Ann Pharmacother 37:564-570
32. Gennari C (2002) Analgesic effect of calcitonin in osteoporosis. Bone 30 [Suppl 5]: 67S-70S
33. Gennari C, Agnusdei D, Camporeale A (1991) Use of calcitonin in the treatment of bone pain associated with osteoporosis. Calcif Tissue Int 49 [Suppl 2]:S9-S13
34. Kanis JA, McCloskey EV (1999) Effect of calcitonin on vertebral and other fractures. QJM 92:143-149
35. Silverman SL, Azria M (2002) The analgesic role of calcitonin following osteoporotic fracture. Osteoporos Int 13:858-867
36. Lyritis GP, Trovas G (2002) Analgesic effects of calcitonin. Bone 30 [Suppl 5]:71S-74S
37. Spigset O, Mjorndal T, Vinge E, Lerner UH (1993) Calcitonin as medication in pain? [Kalcitonin som lakemedel vid smarta?] Nor Med 108(2):54-57
38. Kelly Mexia L, Gonzalez Ibanez J (1988) Effectiveness of synthetic salmon calcitonin in the osteoporosis of the spine. [Eficacia de la calcitonina sintetica de salmon en episodios agudos de fracturas por osteoporosis de columna vertebral.] Compend Invest Clin Latin 8(2):23-31
39. Attali G, Levernieux J, Caulin F (1987) Recent crush fracture syndrome. Effect of salmon calcitonin. Results of three double-blind studies and one open study. In: Christiansen C, Johansen JS, Riis BJ (eds) Osteoporosis 1987/international symposium on osteoporosis. Osteopress, Copenhagen, pp 930-932
40. Dilsen G, Sindel D, An C (1996) Effect of nasal calcitonin on pain in osteoporotic patients with vertebral fractures. Osteoporos Int 6 [Suppl 1]:259
41. Szejnfeld VL, Ferraz MB, Sato EI, Atra E (1991) Analgesic effect of salmon calcitonin in patients with osteoporosis: randomized double-blind method. [Efeito analgesico da calcitonina de salmao em pacientes acometidos por osteoporose: estudo duplo cego randomizado.] Rev Bras Orthop 26(3):81-85
42. Arinoviche R, Arriagada M, Jacobelli S, Massardo L, Rivero S, Aris H et al (1987) Analgesic effect of calcitonin in osteoporotic patients with acute vertebral fracture. [Calcitonina en dolor agudo por fractura vertebral en osteoporosis.] Rev Med Chil 115:1039-1043
43. Lyritis GP, Tsakalakos N, Magiasis B, Karachalios T, Yiatzides A, Tsekoura M (1991) Analgesic effect of salmon calcitonin in osteoporotic vertebral fractures: a double-blind placebo-controlled clinical study. Calcif Tissue Int 49:369-372
44. Lyritis GP, Paspati I, Karachalios T, Ioakimidis D, Skarantavos G, Lyritis PG (1997) Pain relief from nasal salmon calcitonin in osteoporotic vertebral crush fractures. Acta Orthop Scand 68 [Suppl 275]:112-114
45. Lyritis GP, Ioannidis GV, Karachalios T, Roidis N, Kataxaki E, Papaioannou N et al (1999) Analgesic effect of salmon calcitonin suppositories in patients with acute pain due to recent osteoporotic vertebral crush fractures: A prospective double blind, randomized, placebo-controlled clinical study. Clin J Pain 15:284-289
46. Pun KK, Chan LWL (1989) Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures. Clin Ther 11:205-209
47. Moher D, Schultz KF, Altman DG (2001) The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357:1191-1194
48. LeLorier J, Gregoire G, Benhaddad A, Lapierre J, Derderian F (1997) Discrepancies between meta-analysis and subsequent large randomized, controlled trials. N Engl J Med 337:536-542